Clinical Trial Update: Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth [Phase 3]

View source ↗

Summary

Phase 3 trial update on anti-HIV drugs for treating infants who acquired HIV infection at birth; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2018-11-30